Clinical Trial Detail

NCT ID NCT03568994
Title Atovaquone (Mepron) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Baylor College of Medicine
Indications

acute myeloid leukemia

Therapies

Atovaquone + Cytarabine + Daunorubicin + Etoposide

Atovaquone + Cytarabine + Daunorubicin + Gemtuzumab ozogamicin

Age Groups: adult child

No variant requirements are available.